Clinical trials
Terminated Phase 2 trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
739 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 3 |
| 2002 | 4 |
| 2003 | 7 |
| 2004 | 9 |
| 2005 | 12 |
| 2006 | 31 |
| 2007 | 38 |
| 2008 | 37 |
| 2009 | 41 |
| 2010 | 42 |
| 2011 | 38 |
| 2012 | 39 |
| 2013 | 26 |
| 2014 | 33 |
| 2015 | 27 |
| 2016 | 27 |
| 2017 | 40 |
| 2018 | 44 |
| 2019 | 52 |
| 2020 | 26 |
| 2021 | 61 |
| 2022 | 43 |
| 2023 | 27 |
| 2024 | 19 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 739 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 34 |
| Novartis Pharmaceuticals | 33 |
| University Health Network, Toronto | 24 |
| GlaxoSmithKline | 20 |
| Bristol-Myers Squibb | 17 |
| Gilead Sciences | 16 |
| Boehringer Ingelheim | 15 |
| Sanofi | 13 |
| AHS Cancer Control Alberta | 12 |
| Amgen | 12 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 29 |
| Breast Neoplasms | 27 |
| Neoplasms | 22 |
| Crohn Disease | 18 |
| Alzheimer Disease | 17 |
| Neoplasm Metastasis | 17 |
| Pain | 16 |
| Dermatitis, Atopic | 15 |
| Prostatic Neoplasms | 15 |
| Asthma | 13 |
Trials
Showing 1 to 25 of 739. Each trial links to its page on Pharma Observatory.
639 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.